Bryan Remaily
The Ohio State University(US)
Publications by Year
Research Areas
Nutrition and Health in Aging, Monoclonal and Polyclonal Antibodies Research, Muscle Physiology and Disorders, Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor(2020)33 cited
- → Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humans(2021)19 cited
- → Antibody Drug Clearance: An Underexplored Marker of Outcomes with Checkpoint Inhibitors(2023)10 cited
- → Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia(2023)10 cited
- → The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic Cancer(2022)9 cited
- → Intramuscular CMT‐167 Tumours Produce a Mild Cachexia Phenotype in C57BL/6J Mice(2025)2 cited
- → 678 The neonatal Fc receptor is elevated in monocyte-derived immune cells in pancreatic cancer(2021)1 cited
- → Associations between body composition measurements (BCM) and phase 1 (P1) oncology clinical trial outcomes.(2022)
- → A Novel Mouse Model to Identify Antigen-Specific Immune Responses in Pancreatic Cancer Cachexia(2026)